Pricing Log in Create free account

MediWound Ltd. (MDWD) vs Entrada Therapeutics, Inc. (TRDA)

MediWound Ltd. and Entrada Therapeutics, Inc. are both Biotechnology companies. MediWound Ltd. and Entrada Therapeutics, Inc. are of similar size ($191.5M and $184.0M). MediWound Ltd. grew revenue faster over the last twelve months: −40.3% against −93.5%. MediWound Ltd. has the higher net margin (−170.1% vs −4,058.0%) and the lower return on invested capital (−6,551.8% vs −2,009.0%). Across the 16 metrics below, MediWound Ltd. leads on 9 and Entrada Therapeutics, Inc. on 7.

Valuation

Metric MDWD TRDA Biotechnology median
P/E n/m n/m 10.60
P/S 15.48 52.10 9.40
P/B 5.15 1.04 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 12.58 3.57 9.02
Earnings yield (11.23%) (78.53%) (32.88%)
Free cash flow yield (15.56%) (65.80%) (23.13%)

Profitability

Metric MDWD TRDA Biotechnology median
Gross margin 15.46% 100.00% 68.51%
Operating margin (267.75%) (4,303.82%) 0.00%
Net margin (170.10%) (4,057.98%) 0.00%
Free cash flow margin (240.47%) (3,428.06%) 0.00%
Return on equity (75.42%) (59.88%) (51.96%)
Return on assets (29.06%) (47.48%) (46.06%)
Return on invested capital (6,551.77%) (2,008.96%) 0.00%

Growth

Metric MDWD TRDA Biotechnology median
Revenue growth (TTM) (40.26%) (93.54%) 6.76%
EPS growth (last fiscal year) 30.69% (306.55%) 29.88%
Revenue growth, 5-year CAGR (4.87%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDWD TRDA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.32 7.85 4.97
Net debt to EBITDA 2.27 1.88 1.01

Dividend

Metric MDWD TRDA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MDWD TRDA Biotechnology median
Market cap 183.97m 191.45m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack